Jane Street
CRBP icon

Jane Street’s Corbus Pharmaceuticals CRBP Stock Holding History

Jane Street’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$687K Buy
73,193
+45,129
+161% +$380K ﹤0.01% 7309
2025
Q4 		$228K Sell
28,064
-30,087
-52% -$371K ﹤0.01% 9449
2025
Q3 		$736K Buy
58,151
+39,273
+208% +$374K ﹤0.01% 6980
2025
Q2 		$130K Sell
18,878
-2,983
-14% -$21.7K ﹤0.01% 8833
2025
Q1 		$116K Sell
21,861
-12,271
-36% -$108K ﹤0.01% 8738
2024
Q4 		$403K Buy
34,132
+22,245
+187% +$373K ﹤0.01% 7222
2024
Q3 		$245K Buy
11,887
+1,595
+15% +$81.6K ﹤0.01% 8353
2024
Q2 		$466K Sell
10,292
-22,108
-68% -$930K ﹤0.01% 7136
2024
Q1 		$1.27M Buy
+32,400
New +$799K ﹤0.01% 4964
2022
Q3 		– Sell
-2,780
Closed -$21K – 9783
2022
Q2 		$21K Buy
2,780
+638
+30% +$6.17K ﹤0.01% 9145
2022
Q1 		$34K Sell
2,142
-510
-19% -$6.76K ﹤0.01% 9799
2021
Q4 		$49K Buy
2,652
+2,059
+347% +$55.8K ﹤0.01% 9540
2021
Q3 		$18K Sell
593
-343
-37% -$13.5K ﹤0.01% 9757
2021
Q2 		$51K Sell
936
-1,448
-61% -$80.4K ﹤0.01% 9500
2021
Q1 		$141K Buy
2,384
+620
+35% +$40.8K ﹤0.01% 8488
2020
Q4 		$66K Sell
1,764
-1,168
-40% -$43.7K ﹤0.01% 7288
2020
Q3 		$158K Buy
2,932
+998
+52% +$181K ﹤0.01% 6565
2020
Q2 		$487K Buy
1,934
+1,430
+284% +$289K ﹤0.01% 5119
2020
Q1 		$79K Buy
+504
New +$85.2K ﹤0.01% 5002
2017
Q1 		– Sell
-2,255
Closed -$572K – 4187
2016
Q4 		$572K Buy
2,255
+1,734
+333% +$397K ﹤0.01% 2712
2016
Q3 		$106K Buy
+521
New +$64.8K ﹤0.01% 3838

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's CRBP Position: Q1 2026 in Review

Jane Street increased its Corbus Pharmaceuticals (CRBP) stake by 161% in Q1 2026, buying an estimated $380K and bringing the position to 73,193 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #7309.

Jane Street first reported a position in CRBP in Q3 2016 and has held it in 21 quarters since. The position peaked at $1.27M in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Jane Street held 73,193 shares of Corbus Pharmaceuticals worth $687K as of Q1 2026.
  • Jane Street bought 45,129 Corbus Pharmaceuticals shares in Q1 2026, an estimated $380K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7309 holding.
  • Jane Street first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 21 quarters since.
  • Jane Street's Corbus Pharmaceuticals position peaked at $1.27M in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.